Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-17

FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application from Prasco Laboratories for aliskiren hemifumarate (aliskiren), enabling the marketing of a generic version of the anti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aliskiren (Aliskiren)

Snippet

SUPPL AP for ALISKIREN (ALISKIREN HEMIFUMARATE)